BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184
11 results:

  • 1. cxcr4 mediates leukemic cell migration and survival in the testicular microenvironment.
    Skroblyn T; Joedicke JJ; Pfau M; Krüger K; Bourquin JP; Izraeli S; Eckert C; Höpken UE
    J Pathol; 2022 Sep; 258(1):12-25. PubMed ID: 35522562
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Different chemokine profile between systemic and testicular diffuse large B-cell lymphoma.
    Ollikainen RK; Kotkaranta PH; Kemppainen J; Teppo HR; Kuitunen H; Pirinen R; Turpeenniemi-Hujanen T; Kuittinen O; Kuusisto MEL
    Leuk Lymphoma; 2021 Sep; 62(9):2151-2160. PubMed ID: 33856274
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
    Lobo J; Gillis AJM; van den Berg A; Looijenga LHJ
    BMC Cancer; 2020 Aug; 20(1):728. PubMed ID: 32758242
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular signatures identified by integrating gene expression and methylation in non-seminoma and seminoma of testicular germ cell tumours.
    Mallik S; Qin G; Jia P; Zhao Z
    Epigenetics; 2021; 16(2):162-176. PubMed ID: 32615059
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
    Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients.
    Kawamoto K; Miyoshi H; Yoshida N; Takizawa J; Sone H; Ohshima K
    Am J Surg Pathol; 2016 Nov; 40(11):1473-1483. PubMed ID: 27631510
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration.
    Storch E; Mark T; Avecilla S; Pagan C; Rhodes J; Shore T; van Besien K; Cushing M
    Transfusion; 2015 Aug; 55(8):2010-6. PubMed ID: 25808119
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Phenotype profiling of primary testicular diffuse large B-cell lymphomas.
    Menter T; Ernst M; Drachneris J; Dirnhofer S; Barghorn A; Went P; Tzankov A
    Hematol Oncol; 2014 Jun; 32(2):72-81. PubMed ID: 23949965
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Plerixafor and autologous stem cell transplantation: impressive result in a chemoresistant testicular cancer patient treated with high-dose chemotherapy.
    De Blasio A; Rossi L; Zappone E; Ortu La Barbera E; Salvatori R; Pacilli M; Carbone A; Zaccarelli E; Papa A; Tomao S
    Anticancer Drugs; 2013 Jul; 24(6):653-7. PubMed ID: 23698254
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Plerixafor enables successful hematopoietic stem cell collection in an extensively pretreated patient with testicular cancer.
    Saure C; Weigelt C; Schroeder T; Klärner V; Galonska L; Haas R; Kobbe G
    Acta Haematol; 2010; 124(4):235-8. PubMed ID: 21099212
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical and biological significance of CXCL12 and cxcr4 expression in adult testes and germ cell tumours of adults and adolescents.
    Gilbert DC; Chandler I; McIntyre A; Goddard NC; Gabe R; Huddart RA; Shipley J
    J Pathol; 2009 Jan; 217(1):94-102. PubMed ID: 18839394
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.